Suppr超能文献

老年西班牙裔人群中阿尔茨海默病和轻度认知障碍的血清蛋白谱。

Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.

作者信息

Villarreal Alcibiades E, O'Bryant Sid E, Edwards Melissa, Grajales Shantal, Britton Gabrielle B

机构信息

Centro de Neurociencias y Unidad de Investigación Clínica, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Ciudad del Saber 219, Clayton, Apartado Postal 0843-01103, República de Panamá

Department of Biotechnology, Acharya Nagarjuna University, Guntur, India.

出版信息

Neurodegener Dis Manag. 2016 Jun;6(3):203-13. doi: 10.2217/nmt-2015-0009. Epub 2016 May 27.

Abstract

AIM

To describe the biomarker profiles in elderly Panamanians diagnosed with Alzheimer's disease (AD), mild cognitive impairment (MCI) or no impairment using serum-based biomarkers.

METHODS

Twenty-four proteins were analyzed using an electrochemiluminescence-based multiplex biomarker assay platform. A biomarker profile was generated using random forest analyses.

RESULTS

Two proteins differed among groups: IL-18 and T-lymphocyte-secreted protein I-309. The AD profile was highly accurate and independent of age, gender, education and Apolipoprotein E ε4 status. AD and MCI profiles had substantial overlap among the top markers, suggesting common functions in AD and MCI but differences in their relative importance.

CONCLUSION

Our results underscore the potential influence of genetic and environmental differences within Hispanic populations on the proteomic profile of AD.

摘要

目的

使用基于血清的生物标志物来描述被诊断患有阿尔茨海默病(AD)、轻度认知障碍(MCI)或无认知障碍的巴拿马老年人的生物标志物谱。

方法

使用基于电化学发光的多重生物标志物检测平台分析24种蛋白质。使用随机森林分析生成生物标志物谱。

结果

两组之间有两种蛋白质存在差异:白细胞介素-18(IL-18)和T淋巴细胞分泌蛋白I-309。AD谱具有高度准确性,且独立于年龄、性别、教育程度和载脂蛋白Eε4状态。AD和MCI谱在顶级标志物之间有大量重叠,表明在AD和MCI中存在共同功能,但它们各自的相对重要性有所不同。

结论

我们的结果强调了西班牙裔人群中遗传和环境差异对AD蛋白质组学谱的潜在影响。

相似文献

1
Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.
Neurodegener Dis Manag. 2016 Jun;6(3):203-13. doi: 10.2217/nmt-2015-0009. Epub 2016 May 27.
2
Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Exp Gerontol. 2013 Dec;48(12):1428-35. doi: 10.1016/j.exger.2013.09.006. Epub 2013 Oct 7.
4
Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort.
Gerontology. 2012;58(1):41-9. doi: 10.1159/000324522. Epub 2011 Mar 23.
8
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
J Alzheimers Dis. 2010;22(4):1305-11. doi: 10.3233/JAD-2010-100921.

引用本文的文献

2
Pyroptosis in Alzheimer's Disease: Mechanisms and Therapeutic Potential.
Cell Mol Neurobiol. 2025 Jun 17;45(1):57. doi: 10.1007/s10571-025-01579-5.
6
Association of inflammation and cognition in the elderly: A systematic review and meta-analysis.
Front Aging Neurosci. 2023 Feb 6;15:1069439. doi: 10.3389/fnagi.2023.1069439. eCollection 2023.
7
Advances, obstacles, and opportunities for machine learning in proteomics.
Cell Rep Phys Sci. 2022 Oct 19;3(10). doi: 10.1016/j.xcrp.2022.101069. Epub 2022 Sep 22.
8
Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.
Alzheimers Dement. 2022 Feb;18(2):240-250. doi: 10.1002/alz.12404. Epub 2021 Jul 26.
9
The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis.
Neurol Sci. 2022 Jan;43(1):285-298. doi: 10.1007/s10072-021-05343-7. Epub 2021 May 25.
10
Improved Discrimination of Disease States Using Proteomics Data with the Updated Aristotle Classifier.
J Proteome Res. 2021 May 7;20(5):2823-2829. doi: 10.1021/acs.jproteome.1c00066. Epub 2021 Apr 28.

本文引用的文献

1
2
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research.
Alzheimers Dement. 2015 May;11(5):549-60. doi: 10.1016/j.jalz.2014.08.099. Epub 2014 Oct 1.
4
Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.
Schizophr Res. 2014 Apr;154(1-3):23-9. doi: 10.1016/j.schres.2014.02.005. Epub 2014 Feb 26.
5
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
Mol Neurobiol. 2014 Oct;50(2):534-44. doi: 10.1007/s12035-014-8657-1. Epub 2014 Feb 25.
6
Developing novel blood-based biomarkers for Alzheimer's disease.
Alzheimers Dement. 2014 Jan;10(1):109-14. doi: 10.1016/j.jalz.2013.10.007.
7
Elevated CNS inflammation in patients with preclinical Alzheimer's disease.
J Cereb Blood Flow Metab. 2014 Jan;34(1):30-3. doi: 10.1038/jcbfm.2013.183. Epub 2013 Oct 23.
8
Molecular neuropsychology: creation of test-specific blood biomarker algorithms.
Dement Geriatr Cogn Disord. 2014;37(1-2):45-57. doi: 10.1159/000345605. Epub 2013 Jan 3.
9
Does ethnicity moderate dementia's biomarkers?
Neurobiol Aging. 2014 Feb;35(2):336-44. doi: 10.1016/j.neurobiolaging.2013.08.006. Epub 2013 Sep 18.
10
Inflammatory process in Alzheimer's Disease.
Front Integr Neurosci. 2013 Aug 13;7:59. doi: 10.3389/fnint.2013.00059. eCollection 2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验